Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy.
Yakushijin
Yoshihiro
Y
Cancer Center of Ehime University Hospital, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 7910295, Japan. yoshiyak@m.ehime-u.ac.jp
Shikata
Hisaharu
H
Takaoka
Ikue
I
Horikawa
Tamami
T
Takeuchi
Kazuhito
K
Yamanouchi
Jun
J
Azuma
Taichi
T
Narumi
Hiroshi
H
Hato
Takaaki
T
Yasukawa
Masaki
M